Health Care · Biological Products, (No Diagnostic Substances) · NYSE · CIK 1739174 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $0.14 · Day +0.51% · Mkt cap $4M · 1Y −98.7% · Off 52W high −98.9% · Vol (1Y) 203.4% Price2023-08-21 → 2026-08-19 PHGE close: $68 on 2023-08-21 to $0 on 2026-08-19. Split-adj closes · 240 of 1,856 · price returnⓘ At a glance | Short interest1.8% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−0.02% | | Top-10 13F concentration100.0% | | Next report (est.)2026-08-20 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$45.5M | | ROIC−4019.4% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−92.7% | | 1Y−98.7% | | 3Y−99.8% | | 5Y−100.0% | | Since incept. (ann.)−72.1% |
Total return · from 2019-03-13ⓘ Risk | Ann. volatility (1Y)203.4% | | Ann. volatility (3Y)188.1% | | Sharpe (1Y)−1.26 | | Sharpe (3Y)−0.41 | | Max drawdown (1Y)−98.9% | | Max drawdown (3Y)−99.9% | | Beta (3Y vs SPY)0.18 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | 131,272 | $492,795 | 8.24% | +0.0% | | Nantahala Capital Management, LLC | 114,795 | $430,940 | 7.20% | +0.0% | | Ikarian Capital, LLC | 19,473 | $73,102 | 1.22% | +0.0% | | MORGAN STANLEY | 19,100 | $71,701 | 1.20% | new | | JPMORGAN CHASE & CO | 14,135 | $63,466 | 0.89% | +0.0% | | JANE STREET GROUP, LLC | 11,829 | $44,406 | 0.74% | new | | BARCLAYS PLC | 1,316 | $4,940 | 0.08% | +0.0% | | UBS Group AG | 573 | $2,151 | 0.04% | −74.9% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-05-20 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-03-31 | 2026-05-20 | $7.38 | — | — | — | | 2025-09-30 | 2025-11-12 | — | — | — | — | | 2025-06-30 | 2025-08-13 | — | — | — | — | | 2025-03-31 | 2025-05-15 | — | — | — | — |
As-reported XBRL · next 2026-08-20 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
